Share Twitter LinkedIn Facebook Email Nikhil C. Munshi, M.D of Dana Farber Cancer Institute discusses the positive results from pivotal KarMMa study of Ide-cel in MM Read here:Â https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-and-bluebird-bio-present-updated-positive
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read
